Salk researchers, led by Susan Kaech, have found that the tumor microenvironment contains an abundance of oxidized fat molecules, which, when ingested by the killer T cells, suppresses their ability to kill cancer cells.
FDA has approved Ayvakit (avapritinib) for adult patients with advanced systemic mastocytosis, including patients with aggressive systemic mastocytosis, systemic mastocytosis with an associated hematological neoplasm, and mast cell leukemia.
Miruna Sasu spent more than 20 years as a digital health and innovation expert at life sciences companies—then came a realization
Caryn Lerman has stepped in as president of the Association of American Cancer Institutes. Lerman, director of USC Norris Comprehensive Cancer Center and associate dean for cancer programs at the University of Southern California, was the AACI president-elect.
FDA’s Oncology Center of Excellence has launched the “Send Your Oncology Research Questions to FDA” crowdsourcing challenge.
Joseph A. Sparano was named chief of hematology and medical oncology and deputy director of The Tisch Cancer Institute of Mount Sinai Health System.
Edward Kim was named medical director for the Office of Clinical Research at UC Davis Comprehensive Cancer Center, effective July 1.
David Klimstra was named chief medical officer of Paige, effective August 2021.
Bridget F. Koontz was named U.S. chief medical officer of the Deputy Group and Neal D. Shore was named U.S. chief medical officer of surgery and urology at GenesisCare.
Friends of Cancer Research has launched Step 2 of the ctDNA for Monitoring Treatment Response (ctMoniTR) Project.
